Sugi Predict

Sugi Predict / Compounds / SCHEMBL29647870

SCHEMBL29647870

SCHEMBL29647870

CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O

nearest known ligand 0.73

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ AGTR1 P30556 6/20 0.73
▸ AGTR2 P50052 6/20 0.73
▸ REN P00797 6/20 0.65
▸ NTSR2 O95665 1/20 0.59
▸ NTSR1 P30989 1/20 0.59
▸ SORT1 Q99523 1/20 0.59
▸ FCGRT P55899 4/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31332289 0.89 AGTR2 (0.91) AGTR1AGTR2RENNTSR2NTSR1
SCHEMBL28485749 0.86 AGTR2 (0.94) AGTR1AGTR2NTSR2NTSR1
Acetic Acid SCHEMBL21811310 0.84 AGTR2 (0.92) AGTR1AGTR2NTSR2NTSR1
SCHEMBL29394721 0.84 AGTR2 (1.00) AGTR1AGTR2
Angiotensin Ii SCHEMBL21811603 0.84 AGTR2 (1.00) AGTR1AGTR2
Angiotensin Ii SCHEMBL29361852 0.84 AGTR2 (1.00) AGTR1AGTR2
Angiotensin Ii SCHEMBL1650427 0.84 AGTR2 (1.00) AGTR1AGTR2
SCHEMBL29619824 0.84 AGTR2 (0.94) AGTR1AGTR2
SCHEMBL29599255 0.84 AGTR2 (0.90) AGTR1AGTR2RENNTSR2NTSR1
Angiotensin Ii SCHEMBL31477824 0.83 AGTR2 (0.98) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230255911-A1 COMPOSITIONS OF BIOACTIVE FULVATE FRACTIONS AND USES THEREOF OMNI BIOCEUTICAL INNOVATIONS, INC. 2023-08-17 — — US claimed
US-11376231-B2 Compositions of bioactive fulvate fractions and uses thereof OMNI BIOCEUTICAL INNOVATIONS, INC. (US) 2022-07-05 — — US claimed
CN-113698452-B Skin repair promoting peptide, preparation method and application thereof 四川丽妍工坊生物科技有限公司 2023-08-18 — — CN disclosed
US-20230255911-A1 COMPOSITIONS OF BIOACTIVE FULVATE FRACTIONS AND USES THEREOF OMNI BIOCEUTICAL INNOVATIONS, INC. 2023-08-17 — — US disclosed
US-11376231-B2 Compositions of bioactive fulvate fractions and uses thereof OMNI BIOCEUTICAL INNOVATIONS, INC. (US) 2022-07-05 — — US disclosed
US-20220184026-A1 COMPOSITIONS OF FULVIC ACID AND CANNABINOID AND USES THEREOF OMNI BIOCEUTICAL INNOVATIONS, INC. 2022-06-16 — — US disclosed